New cancer vaccine could treat some types of pancreatic, colorectal and other deadly forms of the disease // Scientific American
MIT researchers developed technology that allows vaccines to be directly inserted into the lymph nodes to target two of the most common mutations in the KRAS gene, which cause roughly one third of all cancers. “The team modified the small vaccine components to include a fatty acid, which enables the vaccine to effectively hitch a ride on albumin, a common protein found throughout the body. Albumin serves as a molecular shuttle bus, with pockets on its surface where fatty acids can bind to it.”
|